Bart Giddings is a registered patent attorney and a partner at Stoel Rives, LLP. He counsels biotechnology, pharmaceutical, and medical device companies on intellectual property matters, including the creation and management of patent and trademark portfolios. He has significant experience with patent issues unique to biopharmaceuticals and small molecule drug products, genetic technology, drug formulation and delivery, and medical diagnostic testing. His practice includes transactions involving assets of life science companies, competitive intelligence, and patent litigation. Prior to joining Stoel Rives, he was Chief Patent Counsel at NPS Pharmaceuticals.
Bart received his J.D. from Stanford Law School and his Ph.D. in biology from the Massachusetts Institute of Technology. He is listed in Intellectual Asset Management’s IAM Patent 1000: The World’s Leading Patent Practitioners, Chambers USA’s America’s Leading Lawyers for Business and Best Lawyers in America.